PTSD Past, Present, and Future: An excerpt from Stahl’s Illustrated Anxiety, Stress, and PTSD
By Meghan Grady
A surprisingly high percentage of the population will experience at least one traumatic event in their lifetime (trauma being defined as a frightening situation in which one experiences or witnesses the threat of death or injury). Posttraumatic stress disorder (PTSD) is perhaps the most common psychiatric illness to result from exposure to a traumatic event and has a prevalence of 7–8%, with even higher rates for specific subpopulations (e.g., military personnel). This article provides an historical perspective on PTSD as an accepted diagnosis, as well as insights into potential future revisions to the diagnostic criteria in DSM-V.
Read more
Related:
PsychEd Up
|
Second Messenger
|
Mechanism of Action of Serotonin Antagonist Reuptake Inhibitors
These figures explain how serotonin antagonist/reuptake inhibitors (SARIs) can regulate glutamate release.
Read more
Related:
PsychEd Up
|
Back to Basics
|
Psychopharmaceuticals and your Licensing Board
By Drs. Dan Tennenhouse and Marvin Firestone
Prescribing is one of the most common bases for actions by licensing boards against clinicians. How can clinicians protect themselves?
Read more
Related:
PsychEd Up
|
Invited Insights
|
Mirtazapine
Mirtazapine: Dosing Tips and Prescribing Pearls
Read more
Related:
PsychEd Up
|
Tips and Pearls
|
Mechanism of Action of Trazodone: a Multifunctional Drug
By Stephen M Stahl, MD, PhD
Trazodone is a multifunctional drug with dose-dependent pharmacologic actions. Although trazodone has traditionally been used as a low dose hypnotic, a new controlled release formulation that has the potential to improve the tolerability of high doses may provide an opportunity to revisit this multifunctional drug as an antidepressant as well.
Read more
Related:
PsychEd Up
|
Essential PsychopharmaSTAHLogy
|